• Dapps:16.23K
  • Blockchains:78
  • Active users:66.47M
  • 30d volume:$303.26B
  • 30d transactions:$879.24M

Sonic Labs and Immunefi announce bug bounty program

user avatar

by Giorgi Kostiuk

a year ago


Sonic Labs has announced a partnership with Immunefi to launch a $2 million bug bounty program. This initiative follows the recent launch of the Sonic mainnet.

Sonic Labs and Immunefi Collaboration

Sonic Labs is partnering with the Immunefi platform to offer a bug bounty program amounting to $2 million. This collaboration aims to enhance the security of the Sonic blockchain running on the Ethereum Virtual Machine. Several exchanges, including Binance, support the token migration from Fantom to Sonic.

Security of the Sonic Protocol

The bug bounty program will enhance the security of the L1 Sonic protocol and the Gateway bridge connecting this blockchain to Ethereum. Sonic is working with leading audit firms, including Open Zeppelin, Quantstamp, and Certora, ensuring the bridge's security.

Support and Prospects of the Program

The Immunefi platform, which has successfully paid out over $110 million to white-hat hackers, offers bug hunting opportunities for Ethereum and other blockchains. As part of the collaboration, up to $1.5 million in rewards may be available for participants of Ethereum-based Attackathons.

Sonic Labs' collaboration with Immunefi highlights a commitment to improving network security and interoperability with other blockchains. Such initiatives emphasize the importance of protection for stable platform operation.

0

Rewards

chest
chest
chest
chest

More rewards

Discover enhanced rewards on our social media.

chest

Other news

Converge Bio's AI Platform Aims to Transform Drug Development

chest

Converge Bio is leveraging its newly acquired $25 million funding to enhance its AI platform, which focuses on drastically reducing the time and costs associated with drug development.

user avatarKenji Takahashi

Converge Bio Secures $25 Million Series A Funding to Transform Drug Discovery

chest

Converge Bio, a startup based in Boston and Tel Aviv, has raised $25 million in Series A funding to enhance AI-driven drug discovery.

user avatarMaria Fernandez

Buterin Continues Charity Donations from Token Sales

chest

Vitalik Buterin continues his practice of selling unsolicited tokens and donating the proceeds to charity, emphasizing ethical considerations in cryptocurrency promotions.

user avatarRajesh Kumar

Vitalik Buterin Sells Unsolicited Tokens for 94 ETH

chest

Ethereum cofounder Vitalik Buterin has sold unsolicited tokens from his wallet, converting them into 94 ETH.

user avatarGustavo Mendoza

Grayscale Segments Crypto Market into Five Vertical Categories

chest

Grayscale has categorized its altcoin candidates into five verticals, reflecting a structured approach to the crypto market.

user avatarMiguel Rodriguez

Decline in FLOW Price Amid Controversial Asset Recovery

chest

The price of FLOW has seen a significant decline following the Flow project's controversial asset recovery actions.

user avatarLuis Flores

Important disclaimer: The information presented on the Dapp.Expert portal is intended solely for informational purposes and does not constitute an investment recommendation or a guide to action in the field of cryptocurrencies. The Dapp.Expert team is not responsible for any potential losses or missed profits associated with the use of materials published on the site. Before making investment decisions in cryptocurrencies, we recommend consulting a qualified financial advisor.